Xiaojun Lin

2.2k total citations
72 papers, 1.6k citations indexed

About

Xiaojun Lin is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Xiaojun Lin has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 28 papers in Surgery and 21 papers in Hepatology. Recurrent topics in Xiaojun Lin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (19 papers). Xiaojun Lin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (19 papers). Xiaojun Lin collaborates with scholars based in China, Hong Kong and United States. Xiaojun Lin's co-authors include Chaobin He, Shengping Li, Zhiyuan Cai, Rong Guo, Zhenwei Peng, Yaojun Zhang, Yu Zhang, Minshan Chen, Xin Huang and Wan Yee Lau and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Xiaojun Lin

71 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaojun Lin China	24	618	498	485	460	257	72	1.6k
José Guilherme Tralhão Portugal	22	391 0.6×	521 1.0×	324 0.7×	557 1.2×	157 0.6×	102	1.8k
Yudong Qiu China	21	356 0.6×	410 0.8×	200 0.4×	544 1.2×	281 1.1×	114	1.4k
Florian P. Reiter Germany	15	471 0.8×	310 0.6×	431 0.9×	225 0.5×	283 1.1×	47	1.4k
Takemi Akahane Japan	24	529 0.9×	260 0.5×	766 1.6×	280 0.6×	140 0.5×	108	1.8k
Toshio Fukusato Japan	26	479 0.8×	449 0.9×	572 1.2×	577 1.3×	341 1.3×	120	2.1k
Soon Woo Nam South Korea	20	653 1.1×	324 0.7×	575 1.2×	161 0.3×	103 0.4×	63	1.4k
Katsuhiro Ogawa Japan	17	209 0.3×	418 0.8×	192 0.4×	299 0.7×	129 0.5×	95	1.3k
Yuzo Kodama Japan	21	351 0.6×	349 0.7×	371 0.8×	491 1.1×	561 2.2×	104	2.1k
Pierluigi Ramadori Germany	25	408 0.7×	235 0.5×	656 1.4×	208 0.5×	149 0.6×	42	1.8k
Neung Hwa Park South Korea	27	891 1.4×	241 0.5×	977 2.0×	231 0.5×	181 0.7×	94	2.0k

Countries citing papers authored by Xiaojun Lin

Since Specialization

Citations

This map shows the geographic impact of Xiaojun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Lin more than expected).

Fields of papers citing papers by Xiaojun Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Lin. The network helps show where Xiaojun Lin may publish in the future.

Co-authorship network of co-authors of Xiaojun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Lin. A scholar is included among the top collaborators of Xiaojun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Lin. Xiaojun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaohui, et al.. (2024). The conditional recurrence-free survival after R0 hepatectomy for locally advanced intrahepatic cholangiocarcinoma: A competing risk analysis based on inflammation-nutritional status. Heliyon. 10(13). e33931–e33931.

Li, Xiaohui, et al.. (2023). Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis. European journal of medical research. 28(1). 606–606. 2 indexed citations

Zhao, Chongyu, et al.. (2023). Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection. Cancer Medicine. 12(24). 21742–21750. 5 indexed citations

Zhao, Chongyu, et al.. (2022). Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts. Frontiers in Oncology. 12. 832038–832038. 2 indexed citations

Wang, Chuandong, Xiaojuan Zhang, Shengtao Lin, et al.. (2022). Superiority of Laparoscopic Gastrojejunostomy Combined With Multimodality Therapy for Gastric Outlet Obstruction Caused by Advanced Gastric Cancer. Frontiers in Oncology. 12. 814283–814283. 2 indexed citations

Cai, Zhiyuan, Chaobin He, Chongyu Zhao, & Xiaojun Lin. (2021). Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 11. 611118–611118. 26 indexed citations

He, Chaobin, Xin Huang, Yu Zhang, Xiaojun Lin, & Shengping Li. (2021). The impact of different metastatic patterns on survival in patients with pancreatic cancer. Pancreatology. 21(3). 556–563. 19 indexed citations

He, Chaobin, Chongyu Zhao, Yu Zhang, Cheng Chen, & Xiaojun Lin. (2021). An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. Journal of Inflammation Research. Volume 14. 1859–1872. 5 indexed citations

He, Chaobin, Shuxin Sun, Yu Zhang, Xiaojun Lin, & Shengping Li. (2020). A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection. Frontiers in Oncology. 10. 1564–1564. 4 indexed citations

10.

He, Chaobin, Xin Huang, Yu Zhang, et al.. (2020). Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 10. 6–6. 22 indexed citations

11.

He, Chaobin, Shuxin Sun, Yu Zhang, Xiaojun Lin, & Shengping Li. (2020). Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment. Frontiers in Oncology. 10. 590–590. 10 indexed citations

12.

He, Chaobin, Yu Zhang, Zhiyuan Cai, & Xiaojun Lin. (2019). <p>The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy</p>. Cancer Management and Research. Volume 11. 1391–1400. 30 indexed citations

13.

Li, QiJiong, et al.. (2019). Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma. BMC Gastroenterology. 19(1). 99–99. 4 indexed citations

14.

He, Chaobin, Yu Zhang, Zhiyuan Cai, & Xiaojun Lin. (2019). Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. BMC Cancer. 19(1). 178–178. 31 indexed citations

15.

He, Chaobin, Yu Zhang, & Xiaojun Lin. (2018). Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis. Journal of Gastrointestinal Surgery. 22(6). 989–997. 11 indexed citations

16.

He, Chaobin, Yu Zhang, Zhiyuan Cai, Xiaojun Lin, & Shengping Li. (2018). Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis. Journal of Cancer. 9(17). 3156–3167. 41 indexed citations

17.

Lin, Xiaojun, Ling Zhou, Xiaoying Dong, et al.. (2018). Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses. Mucosal Immunology. 11(6). 1663–1673. 44 indexed citations

18.

He, Chaobin, Xiang‐Ming Lao, & Xiaojun Lin. (2017). Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. Chinese Journal of Cancer. 36(1). 59–59. 26 indexed citations

19.

Dai, Qiangsheng, Sheng Ye, Xiaojun Lin, et al.. (2014). Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Molecular and Clinical Oncology. 2(6). 1047–1054. 22 indexed citations

20.

Shi, Ming, Jian Chen, Xiaojun Lin, et al.. (2009). Prospective randomized controlled study of transarterial chemoembolization with doxorubicin versus doxorubicin/lobaplatin/mitomycin combination for unresectable hepatocellular carcinoma. Clinical Oncology and Cancer Research. 36(1). 9–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact